Podcasts about therapsil

In this episode, host Ellen Wong invites Steve Rio, the Co-founder of Enfold, to talk about the nature of the 5-MeO-DMT experience. Ellen shares about her experience at Enfold this April.About Mum's GuestSteve Rio is the Co-Founder of Enfold. He's a transformational performance coach, psychedelic guide, spiritual teacher, musician, entrepreneur and investor. His life's work focuses on raising consciousness and helping people realize their full potential. Steve sits on the board of TheraPsil, is an advisor to Numinus, Holos Global, and Nikean Foundation.Steve's Links* Enfold website: https://enfold.org* Enfold on Instagram: https://instagram.com/enfoldinstitute* Steve on Instagram: https://instagram.com/steverioAbout MUMWe are on Youtube! Subscribe to our channel.MUM is produced by ⁠Ellen Wong⁠ and edited by ⁠Stepfanie Aguilar.⁠ Your support allows us to continue creating this podcast. If you enjoy this episode, please take a moment to rate and review. Keep this conversation alive by bringing it to your communities.Follow Mum on Instagram ⁠⁠@mumthepod⁠⁠.If you are interested in working privately with Ellen, visit ⁠tripwithellen.com⁠ to learn more about her mentorship program and her spirit medicine programs. This is a public episode. If you'd like to discuss this with other subscribers or get access to bonus episodes, visit tripwithellen.substack.com/subscribe

Meet Steve Rio -  spiritual coach, entrepreneur, and Co-Founder of Enfold Institute. As a key figure in the psychedelic renaissance, Steve sits on the board of TheraPsil and advises leading companies in this space. His life's work is to raise consciousness and help people realize their full potential. Enfold offers a unique psycho-spiritual model for healing and growth, combining psychedelic intensives, coaching, and community support. They are world leaders in the safe and sacred use of 5-MeO-DMT, helping individuals heal trauma, expand their consciousness, and unlock their true potential. For Steve and his wife Austin, Enfold is the culmination of their life's work—a sacred calling to serve and elevate others during their most transformative moments.Join us for an inspiring conversation as we explore Steve's journey, his work with Enfold, and his approach to expanding consciousness and healing trauma in an intentional community

Meet Steve Rio, Co-Founder of Enfold, a spiritual coach, musician, entrepreneur, and investor. As a key figure in the psychedelic renaissance, Steve sits on the board of TheraPsil and advises leading companies in this space. His life's work is to raise consciousness and help people realize their full potential. Enfold offers a unique psycho-spiritual model for healing and growth, combining psychedelic intensives, coaching, and community support. They are world leaders in the safe and sacred use of 5-MeO-DMT, helping individuals heal trauma, expand their consciousness, and unlock their true potential. For Steve and his wife Austin, Enfold is the culmination of their life's work—a sacred calling to serve and elevate others during their most transformative moments.Join us for an inspiring conversation as we explore Steve's journey, his work with Enfold, and his approach to living a balanced and purposeful life.Follow Steve:  Instagram Follow Enfold: Instagram | LinkedIn | YouTube | WebsiteFollow Explore84:  Instagram | TikTok | YouTube | LinkedIn | Website 

The Healing Journey of Psilocybin with Tara Portelli Tara Portelli CNHP, CHN, CHt, PCP(Psilocybin Guide, Founder) As founder of Arcadia Healing Sanctum, Tara Portelli has incredible success with her work in the field of Psilocybin Therapy in the retreat setting. She has had the opportunity to work with many high profile clients such as the Comptroller for many UK Ambassadors, a top Robotics Surgeon and numerous medical professionals including, doctors, surgeons, nurses, from all over the world. Her work has extended to first responders, war veterans and people who have limited success with conventional treatments. As founder of Arcadia Healing Sanctum, the reputation her organization has withheld has been recognized by the prestigious, Imperial College of London and now has become an affiliate organization, supporting ongoing research in the field of Psychedelics for mental health. Tara stumbled into her experience with Psilocybin, while on a self healing journey in Tulum, Mexico. As a former Paramedic who has suffered with PTSD, anxiety and some depression, she didn't even know how deep her pain was, until she had her first full dose of Psilocybin. Her experience left her with a deep sense of self and a feeling of peace that she had never experienced before. Working in Emergency services for 9 years, she saw an increasing rise in mental health and human suffering, as people become prisoners of their own minds and we enter into a “mental health crises”. She started working with this medicine under the guidance of a mushroom healer and began helping others through their own journeys to healing. She studied Psychology and Cultural Anthropology at the University of Calgary and then went on to train in Paramedicine, holding a A-EMCA, license as a Primary Care Paramedic (PCP), practising for nine years. In addition, she holds a credentials as a Certified Natural Health Professional (CNHP), Certified Holistic Nutritionist (CHN) and as a Clinical Hypnotist (CHt), training under renowned psychotherapist, Debbie Papadakis. She is has the ability of helping people dive deep into the subconscious mind and healing the relationship with the true self, as well as healing trauma. She has experience working in a Private Holistic treatment facility for mental health and addictions, as well as a family history of mental illness, creating a very deep and passionate affinity for her work. Tara understands psilocybin and the function it can play on a physiological level. In 2020, she aligned herself with Therapsil, a non-profit organization, advocating for Psilocybin therapy for terminal patients who were suffering from end-of-life distress. She was part of the team that successfully gained the first legal access to Psilocybin for terminal patients in Canada. In the right setting, dose and space, this medicine can offer a very life changing experience to those in need. Tara holds a loving, warm and very safe space for those who are ready to take this journey. Website:

In this MUM episode, PAT counselor Catherine Warnock shares about Psilocybin-Assisted Therapy, ego dissolution versus ego death, and how the sacred mushroom can support in easing the journey towards end of life. About Catherine Warnock: Catherine Warnock is a Licensed Professional Counselor registered in the states of New Mexico, Texas, Washington, and Colorado. Specializing in helping people resolve their trauma, she developed Emotional Triggers Treatment (ETT) and received training in Psilocybin-Assisted Therapy (PAT) at Therapsil in Canada. Catherine has been offering PAT retreats and plant therapy microdosing coaching services since 2022. She also offers training courses to other healing practitioners interested in learning how to guide clients safely and effectively with PAT for relief from anger, anxiety, depression, guilt/shame, relationship issues, unresolved grief, chronic pain, and end-of-life issues. Link with Catherine: Psilocybin-Assisted Therapy Preparation Guide Pamphlet PAT practitioner trainings PAT client retreats MUM Offerings: Water + Fire Grief Circle: a free 60-minute monthly grief/prayer ritual to support our community MUM is produced by ⁠Ellen Wong⁠ and edited by ⁠Stepfanie Aguilar.⁠ Your support allows us to continue creating this podcast. If you enjoy this episode, please take a moment to rate and review. Keep this conversation alive by bringing it to your communities. Follow Mum on Instagram ⁠⁠@mumthepod⁠⁠. If you are interested in working privately with Ellen, visit ⁠tripwithellen.com⁠ to learn more about her Death/Birth program and her spirit medicine solo retreats.

CW: End of life care and distressDr. T and the Truth Fairy welcome Michelle Gagnon, a registered nurse with a background in medical assistance in dying. She is currently pursuing her PhD at the University of British Columbia where her research focuses on ethics, therapeutic psychedelics, and health care practices, specifically where they intersect. Michelle shares a wealth of health care experience and knowledge with Dr. T and Truth Fairy. Michelle's masters' research examined moral distress among intensive care nurses losing patients. She explains what moral distress encompasses and how she is researching the potential for psychedelics to help treat folks struggling with it. Dr. T shares a related personal experience that lends perspective to what Michelle is exploring.In conversation with Michelle Gagnon, Dr. T and Truth Fairy learn about Michelle's work with non-profit association TheraPsil, her hopes for the legalization of psychedelics like psilocybin for medical use, the limits of the current health care structure, and how ethics must factor into every aspect of research and practice. There is a lot of insightful information imparted about Canadian research into psychedelics and the individuality of approach necessitated by each person's reaction to medicines in this episode. “I think sometimes with psychedelics as it's framed now, there's a lot of excitement about it and sometimes we can get lost in the hype that this could change things drastically. And it could, but it's not an easy cure, like you said, it's not necessarily even a cure or an assist for everybody. It's not right for everyone. It's just the way I kind of see it is it's another potential tool under our umbrella of other tools. And it's so unique in so many ways. And I think it is, like you mentioned, disrupting potentially a lot of the way we do things, which is exciting.” -  Michelle GagnonAbout Michelle Gagnon, RN:Michelle Gagnon is a registered nurse with a background in emergency critical care and medical assistance in dying. As a by-product of her master's research, which focused on moral distress in pediatric critical care nurses related to the death and dying of child patients, Michelle became interested in the use of psychedelic medicine for distress. She is currently a PhD student at the University of British Columbia with a research focus on the intersection of ethics, therapeutic psychedelics and health care practices. Michelle worked for nonprofit TheraPsil to support Canadians seeking access for medical psilocybin through Health Canada. She also spends time volunteering with the Psychedelic Association of Canada's Ethics Working Group to draft and disseminate articles related to pressing ethical topics in the psychedelic field. In her free time, Michelle is an avid baker and enjoys reading mystery and fantasy. Through mud and snow she enjoys mountain biking the trails where she lives in the traditional territories of the Blackfoot Confederacy, the Tsuut'ina, the Stoney Nakoda nations and the Metis Nation, and all who make their homes in the treaty seven region of Southern Alberta.Resources discussed in this episode:Michelle Gagnon on MediumTheraPsilPsychedelic Association of Canada---Punk Therapy: website |email

https://therapsil.ca/TheraPsil is a small non-profit coalition dedicated to helping Canadians in medical need access legal, psilocybin-assisted psychotherapy and medical psilocybin.TheraPsil was formed in 2019 and is made up of healthcare practitioners, patients, community members, and advocates. To meet our team, click here.In August 2020, after over 100 days of advocating, TheraPsil facilitated precedent-setting and tangible progress in the fight for compassionate access to psilocybin therapy when we helped 4 Canadians suffering from end-of-life distress, due to a terminal illness, access approved 'section 56 exemptions' from the Minister of Health, This was the first time section 56 exemptions for psilocybin had been approved for patients since psilocybin was made a controlled substance in 1974, in Canada marking a water-shed momentAs of January 2022, TheraPsil has now supported 55 patients in 5 different provinces access legal, psilocybin-assisted psychotherapy.We are actively assisting Canadians with existential distress as a result of a past or present terminal or life-threatening diagnosis pursue legal access to psilocybin to be used in conjunction with psychotherapy.New patients who are interested in legally accessing psilocybin therapy can find out more about their options here.TheraPsil looks forward to helping many more Canadians gain access to legal, psilocybin-assisted psychotherapy.As of March 2021, TheraPsil launched and is scaling a psilocybin assisted therapy training program for qualified Healthcare Practitioners. TheraPsil recognizes the importance of developing a pool of suitably trained and trusted TheraPsil Clinical Associates to whom we can refer patients. To learn more, visit our Training Webpage here.TheraPsil is also contributing to current and future psilocybin research. Observational research studies have been designed in collaboration with researchers from McGill University, Northern Ontario School of Medicine, and the world's first Psychedelic Research Centre at Imperial College, London. All eligible patients granted legal access to psilocybin therapy have the opportunity to take part in this research initiative. Find out more about past and present psilocybin research here.Navigating governmental processes in order to access legal and safe psilocybin therapy is complex, cumbersome for patients and healthcare providers and slow, hence why only 58 individuals have gained access with our help so far. We know this is not acceptable and change is urgently needed.TheraPsil is actively advocating for the Federal Government to enact medical psilocybin regulations in Canada to make medical psilocybin, and psilocybin therapy a legal, safe, regulated and accessible treatment option in Canada for all in medical need. To learn more about our advocacy efforts and how you can take action with us visit our Take Action webpage here.As a small non-profit we rely on donations from our community to operate. We cannot continue to support Canadians in accessing legal psilocybin now or continue to advocate for the enactment of medical psilocybin regulations in the future, without your support.If you are supportive of the work our team is doing and want to see psilocybin legalized in Canada, please consider donating. Even small donations help those in need of psilocybin therapy in Canada be able to continue to receive our support.DonateTheraPsil is accepting members. To join TheraPsil as a member, please fill out TheraPsil Membership Form 2021 and submit to support@therapsil.ca.Ladies & Gentleman… You know what I despise! Talking to a robot then waiting in Hold! I woukd like to introduce you to the New Sponser of the TrueLife Podcast! There AI technology dials the company's number, goes through all the stages of interaction, then initiated a callback to you when an operator is connected! Never wait on hold AGAIN!Use PROMO code: TRUELIFEhttps://www.dayapp.net/

Colorado recently voted to legalize psilocybin, the psychedelic compound in magic mushrooms. And as more clinical trials show promising results for psilocybin-assisted therapy, there has been a push in Canada to expand medical access. But is enough known yet about how safe they are? And how effective?See omnystudio.com/listener for privacy information.

❤️ Join Peak Network! Dr. Nicholas Brüss, EdD, LMFT is a paradigm-shifting psychedelic therapist, researcher, and trainer who is passionate about helping people heal, grow, and find freedom in their lives (with and without the use of psychedelic medicine). He's co-therapist and supervisor for the MAPS Phase 3 clinical trial of MDMA-assisted therapy for PTSD. Certified in both Internal Family Systems (IFS) therapy and ketamine-assisted psychotherapy, he's been providing ketamine-assisted IFS therapy in Los Angeles since 2017. Nicholas is the Co-founder and Lead Trainer of the Psychedelic Coalition for Health. He is also a Trainer for therapeutic psilocybin with Therapsil. I would really appreciate it if you left a short review on Apple Podcasts/iTunes! It takes only a minute and I love reading the reviews! Interested in sponsoring the podcast? Email n@naeemmahmood.com ❤️ Connect with Naeem: https://naeemmahmood.com/ Naeem Mahmood is the founder of Peak Network - we are on a mission to unleash human performance! We do this through coaching, thoughtful discussions, and powerful connections! Naeem is a world-renowned peak performance strategist in the areas of leadership, organizational behavior, psychology of achievement, and sales mastery, where he has advised some of the world's top organizations including The US Army, Salesforce, Equinox, and JP Morgan. Naeem was one of Tony Robbins' top national speakers where he delivered 2,000+ talks to over 100,000 people on the psychology of peak performance.

In this episode of the podcast, I bring you a fantastic conversation with Valorie Masuda, Psychedelic Therapist with Roots to Thrive, “Roots to Thrive is Canada's first and only multidisciplinary, non-profit healthcare practice to legally offer evidence-informed, multi-week, group therapy programs that use a community of practice model, uniquely designed to address trauma and to promote resilience, and to also include the option of psilocybin-assisted and ketamine-assisted group therapy.” source: https://rootstothrive.com/about-us/what-is-roots-to-thrive/Valorie is a palliative care physician and general practitioner in oncology working in the Cowichan Valley on Vancouver Island. She is an Associate Professor of Clinical Medicine at the University of British Columbia currently working on a clinical trial demonstrating the feasibility of delivering psilocybin therapy in a group set, setting and integration model with Roots to Thrive. She is certified in psychedelic medicine through the California Institute of Integral Studies and has also received training through Therapsil and Roots to Thrive. Valorie is a Fellow of the College of Family Physicians, specializing in Emergency Medicine and Palliative Care.I am really excited to bring you this conversation. Those of you who have listened to the podcast know that, as a self experimenter, I have dabbled with the use of Psilocybin in microdoses as a way to manage depression and anxiety. Although we don't discuss microdosing in this episode, you will still find a ton of information and insight here as we discuss the use of psilocyban mushrooms in larger doses as a way to help patients deal with existential end of life mental health difficulties. The common thread through it all is that humans have lost their connection to one another. Human connection used to be vital for survival but is something we have lost through the way we now look at our lives with a colonial lense. We also discuss how our dismissal of indigenous culture has negatively affected our long term mental health with our disconnection from community and nature. We chat about how poor mental health is addressed with pharmacology rather than digging down to the roots of trauma and how natural medicinal compounds such as psilocybin can help.I've been wanting to share a conversation like this for some time and I'm so happy to be bringing this to you now.TherapsilRoots to ThriveMultidisciplinary Association For Psychedelic StudiesSave 15% at Redshift Sports when you use the code MB40Save 25% off a consultation at Cycling 101 when you use the code MB40 at checkout.Save 25% at Dynamic Cyclist when you use the promo code MB40 at checkout.Visit Rollingdale CycleThanks to Ottalaus Inc. for their support.Thanks to Spandex Panda for their support.Thanks to Lakeside Bikes in Invermere for supporting me!

Tamara Cherry fills in for Evan Solomon. She speaks with Thomas Hartle, the first Canadian to legally consume psilocybin for medical purposes, about why he is suing the federal government. On today's show:  Christopher Alexander, president of RE/MAX Canada, on whether big investors buying single-family homes could become a trend in this country. Then, we take your calls. An Ontario woman made a life-changing discovery after taking an ancestry DNA test. Carlie McMaster and her sister, Rylee Hall, join the show. The War Room political panel with Tim Powers, Lindsay Maskell and David Moscrop. Thomas Hartle, one of eight plaintiffs suing the federal government over psilocybin access, and Spencer Hawkswell, CEO of TheraPsil, who is supporting Hartle in the challenge.

Spencer is doing phenomenal work, challenging current Canadian laws to legalize psilocybin access for those in medical need. He has helped dozens of Canadians — particularly those with end-of-life depression — get access to psilocybin-assisted psychotherapy. https://therapsil.ca/ Download the Callin app for iOS and Android to listen to this podcast live, call in, and more! Also available at callin.com

In this episode, Victoria Dekker debuts, interviewing the CEO of TheraPsil, Spencer Hawkswell, about the charter challenge that effectively sues the Canadian government for ending psilocybin exemptions for end-of-life patients. www.psychedelicstoday.com

Welcome to the second episode in our series on the potential of psilocybin-assisted therapy to help us live as well as possible with metastatic breast cancer.In this episode, we talk to two women with breast cancer who had legal access to psilocybin-assisted therapy. Journalist and writer Erica Rex participated in a clinical trial at Johns Hopkins after being diagnosed with early-stage breast cancer. Mari Singfield, a young Canadian woman living with MBC, gained access through an exemption to Section 56(1) of the Canadian Controlled Drugs and Substances Act, a process facilitated by the organization, TheraPsil. Both women shared with us the process that they went through to gain legal access to psilocybin-assisted therapy, what the treatment was actually like for them,  and what, if anything, changed in their lives afterward.This series has been led by series producer and co-host, Paula Jayne,  with assistance from co-host Lynda Weatherby, and senior producer and host, Lisa Laudico.Thanks for listening!More info is available in our episode notes for this series on our website:www.ourmbclife.orgGot something to share? Feedback?Email: ourmbclife@sharecancersuupport.orgSend us a voice recording via email or through speakpipe on our website.  Follow us on Facebook, Instagram, and Twitter @ourmbclife

Reefer Reporters - May 19 2022 with Rev Kelly & AlStories include.....Health Canada still hasn't officially begun Cannabis Act's three year review, ‘We don't understand it': Advocates slam Vancouver police raid of low-barrier cannabis program, 'He was a totally different kid': The impact of cannabis oil on the health of children, Drug raid in Norfolk County nets thousands of ‘destroyed' cannabis plants, ADC partners with Alt Magic to launch the first WebXR Cannabis Store in Metaverse, First-ever export of Israeli medical cannabis seeds heads to US, Uruguay's cannabis regulator visits Quebec, Ontario on fact finding mission, We Put Cannabis Brands Tied to Famous Names to the Test to See if They Live Up to the Hype, Havn Life partners with non-profit TheraPsil to bring safe access to psilocybin

Spencer Hawkswell, CEO of Therapsil believes that responsible drug policy requires effective organization and leadership and is dedicated to bringing together the experts and advocates, to facilitate change that results in increased access to compassionate care, harm reduction, and treatment options for those in need. Arron joined the Canadian Armed Forces where he served for 13+ years in an infantry unit spending time in Recce/Sniper platoons including a deployment to Afghanistan with Task Force 1-07, as well as a deployment to Haiti in support of OP Halo in 2004. Arron is an advocate for plant based healing and veterans mental health. - - - @therapsil @arron_vic https://therapsil.ca - - - - - - - - - - - - SUPPORT OUR SPONSORS Good F*cking Design Advice - 10% off with code UNITY - www.gfda.co Combat Flip Flops - 25% off with code UNITY - https://combatflipflops.com Brass & Unity - 20% off with code UNITY - http://brassandunity.com Daisy May Hats Co - 15% off with code BRASS - https://daisymayhats.com Lords Of Gastown - 15% off with code VIPUNITY - https://www.lordsofgastown.com - - - - - - - - - - - - - SHOP B&U Jewelry & Eyewear: https://brassandunity.com - - - - - - - - - - - - - Follow #brassandunity - - - - - - - - - - - - - CHARITY Honour House - https://www.honourhouse.ca Vet Solutions - https://vetsolutions.org Heroic Hearts - https://www.heroicheartsproject.org Warrior Angels Foundation - https://warriorangelsfoundation.org All Secure Foundation - http://allsecurefoundation.org Four Seasons Fighters - https://www.fourseasonfighters.org

In this episode of the Daily Mushroom Podcast, we have the wonderful Holly Bennett, Communications Director at TheraPsil. Holly dives into how she got started in a rewarding career with psychedelics. She gives us an inside look into how the Section 56 exemption works and some other possible ways Canadians can access psilocybin psychotherapy without it. Holly is very knowledgeable about her field and sheds light on some questions we are sure many people have about Canada's Special Access Program.

If you were told you had months, weeks or even days left to live...would you care what the law said about consuming psychoactive substances? This week's episode features Spencer Hawkswell the CEO of TheraPsil - a non-profit coalition dedicated to helping Canadians in medical need access legal, psilocybin-assisted psychotherapy to treat end-of-life distress. Spencer believes that responsible drug policy requires effective organization and leadership and is dedicated to bringing together the experts and advocates, to facilitate change that results in increased access to compassionate care, harm reduction, and treatment options for those in need.Tune in to this week's episode to hear how the Land of Maple Leaf implements its patient-centred approach in healthcare. What happened in the UK? Are there lessons to be learnt from Canada?  PsilocybinCannabisTrigeminal neuralgia Patty HajduJean-Yves DuclosHealth CanadaFentanyl Clonazepam Section 56 Exemption Roland R. GriffithsMathew W. JohnsonRobin Carhart-HarrisAnthony P. BossisKetamineHolotropic breathworkCluster headacheADHDAcid (LSD)Medical assistance in dyingLetter to Minister DuclosRe: Proposed Regulations for Medical Access to Psilocybin ★ Support this podcast ★

In this episode of the Daily Mushroom Podcast, we have Dr. Shannon Dames, a professor of nursing at Vancouver Island University. Shannon runs an organization called "Roots to Thrive", a ketamine-assisted group therapy workshop. She recently teamed up with TheraPsil to organize the first-ever legal psilocybin-assisted group therapy workshop. Safe to say she's pretty busy!

Julia Joyes is a neuroscientist and research director at Therapsil, a leading non profit organization making a difference to mental health in Canada. In this episode, we take a closer look at psilocybin's impact on the brain.

Summary:We talk with Dr. Glenn Hartelius — award-winning author, professor, and researcher — about attention strategies, and how psychedelics impacted his depression and migraines. We discuss a breathing exercise that improves sports performance, and how to shift consciousness to the felt-sense of the bodyHighlights:— NUGGET and NOODLE: Feds fund fungi for first time in 50 years (0:51)— Psychology of the felt-sense of the body (4:40)— Opening the control panel of your body and changing the state of your consciousness (6:18)— Information is not just about thoughts (9:42)— Glenn's experience with Ketamine addressing depression (11:38)— Glenn's breathing exercise for precision sports performance (16:28)— Psychedelics curing Glenn's migraines (23:52)— SOUL SEARCH: favorite book and top mind altering substance (24:53)— SLAP and a CLAP: Field Trip and TheraPsil (27:37)Dr. Glenn Hartelius:He is an award-winning scholar and researcher who has developed precise, step-by-step processes for accessing and using states of consciousness to cultivate exceptional human skills in leadership and performance—including how to use command presence, how to inspire, develop rapport with others, hold the attention of an audience, sustain focus, and access motivation and out of the box thinking. On the personal level, these skills help in developing quiet inner calm and authentic emotional and physical intimacy. This work is backed up with scientific research in the neuroscience and phenomenology of mindfulness, flow, and other exceptional states. As co-author of The Ketamine Papers and other ongoing research, Glenn is participating in the current revival of scientific interest in this legal and promising psychedelic antidepressant. His motivation in advancing the study of ketamine therapy is based on how quickly and effectively it can relieve symptoms of depression—often in just a few hours. He also works with FireflyVR as a content expert developing virtual reality education products to help individuals prepare themselves for ketamine therapy.As Main Editor of the International Journal of Transpersonal Studies, a peer-reviewed scientific journal that focuses on whole person approaches to psychology and wellness, Glenn has brought this publication from fewer than 25 subscribers to almost 100,000 article downloads per year by nearly 50,000 total users. As former professor and founding chair of a PhD program in Integral and Transpersonal Psychology, he attracted more than 100 doctoral students to his doctoral program in just four years. As co-editor of The Wiley-Blackwell Handbook of Transpersonal Psychology, Glenn has played a key role in the revival of transpersonal psychology, and in identifying and cultivating a second wave of the field based on embodiment, social embeddedness, diversity, and transformation.Glenn is transitioning out of the university setting to spend more time doing scientific research and to give more room to his small boutique coaching practice where he teaches and applies the attentional skills he has developed. The skills that Glenn teaches are based in bottom-up emergence of one's own unique capacities and creativity—one that complements more conventional approaches to management of feelings and behavior. As such, working with Glenn is an entry onto a path that opens toward more integrated ways of bringing one's whole self to every area of life. Find Glenn here:glennhartelius@mac.comhttps://glennhartelius.com/ 

Natasha Fearnley is a registered nurse the clinical intake director for the non profit organization Therapsil. Therapsil helps patients that are suffering from end of life anxiety gain access to psilocybin therapy. Natasha shares her fascinating story of working as a nurse in palliative care and how they lead her to her new role working with psilocybin therapy.

Now brought to you by Scout Magazine. Marijuana was legalized in Canada just a few years back and we are certain there are not many who are upset with this. Psilocybin, the chemical altering compound found in "magic mushrooms" is still illegal. It has been since 1974. This needs to change. Enter in Spencer Hawkswell. He's the CEO of a new Victoria based non-profit called TheraPsil. He helped co-found this venture with his friend and mentor Dr. Bruce Tobin who is a psychotherapist. Together they've helped a small group of Canadians in times of need, specifically end of life treatment. In doing so they've given those individuals at this time a new medicine with which to work with, one that isn't addictive and completely natural.  The results have been life changing. But they want to help all Canadians and until Health Canada changes the law regarding the manufacture, production and use of psilocybin, their hands are limited. Enter a few weeks ago where they submitted a 165 page proposal detailing how psilocybin should be legalized. In this interview Spencer goes through this document, how he sees this process unfolding and what psilocybin access and treatment will look like. You can hear it in his voice, he wants to help and we appreciate his candour and empathy for this cause. We're confident you'll enjoy this one. I say we, because Mickey is back! therapsil.caTheraPsil is a non-profit coalition dedicated to helping Canadians in medical need access legal, psilocybin-assisted psychotherapy to treat end-of-life distress.TheraPsil was formed in 2019 and is made up of healthcare professionals, patients, community members, and advocates. To meet our team, click here.After over 100 days of advocating, TheraPsil facilitated precedent-setting and tangible progress in the fight for compassionate access to psilocybin therapy when it helped 4 Canadians suffering from end-of-life distress, due to a terminal illness, access approved 'section 56 exemptions' from the Minister of Health, on August 4th 2020. This was the first time section 56 exemptions for psilocybin had been approved for patients since psilocybin was made a controlled substance in 1974, in Canada.As of March 2021, TheraPsil has now supported 27 patients in 5 different provinces access legal, psilocybin-assisted psychotherapy.***Scout is one of Vancouver's leading food and culture magazines. If you're wanting to learn more about the city's food and cultural sphere with regards to community news, new restaurant openings, essential guides to some of the city's best offerings as well as who's hiring, Scout is where you should go. They also have a sister website called Islandist. Same type of content only Island driven. That's Islandist.ca.We're proud to have Scout as our presenting sponsor as we believe what they “Scout out” is an excellent compliment to what we're offering here with Track and Food. Do check them out. scoutmagazine.ca

In the latest episode of the Psychedelic Spotlight podcast, we speak with Spencer Hawkswell who is the CEO of TheraPsil, a non-profit coalition of healthcare professionals, patients, and advocates dedicated to obtaining legal access to psilocybin-assisted psychotherapy for Canadians in medical need.In our conversation with Spencer, we discuss the different challenges he and the TheraPsil team are focused on overcoming to increase access to psilocybin-assisted psychotherapy for patients in Canada suffering through end-of-life distress, and why psilocybin, in particular, is capable of offering certain patients relief from their suffering.*To learn more about the company discussed in this episode and the work they're doing, visit their website: TheraPsil.ca*Subscribe to our newsletter to get the latest industry news: PsychedelicSpotlight.comInstagram: @PsycSpotlightTwitter: @PsycSpotlightFacebook: PsychedelicSpotlightYouTube: PsychedelicSpotlightLinkedIn: Psychedelic-Spotlight*This interview was recorded on July 20, 2021.

Hello friends! For those of you who appreciate the episodes about advocacy, regulations, and the legalities around increasing access to psychedelics - this one is for you! We spoke with Spencer Hawkswell, CEO of Therapsil, about what a world with more (and equal) access to psilocybin therapy would look like. We also chatted about the very impressive accomplishments that Therapsil has accomplished for the movement.What we talked about:How Spencer got involved in this space and TherapsilThe milestones that Therapsil have accomplished in helping patients gain access to psilocybin therapy in CanadaWorking with compassionate Health Minister Patty Hadju in Ottawa, Canada to grant patient accessCompassionate access through section 56 is now legal in CanadaThe process of legalizing Psilocybin in Canada and working through the politicsThe emotional and psychological experience of end of life distressHow Psilocybin helps people find peace with deathPreparation and Integration modalities that help patients process what they experienceHow increased access may look in the future and ensuring that both patients AND health care practitioners are prepared for increased accessThe Charter of Rights & Freedoms and psychedelic medicine useWhy clinical access points to psychedelics have more of a reach than the underground movementSimple things that we and the government can enact today to make access easier for those who need itMentioned in the episode:Food of the Gods [book]Psilocybin produces substantial and sustained decreases in depression and anxiety in patients with life-threatening cancer: A randomized double-blind trial [study]Mushrooms and the Sacred Cross (book)Carl Jung [book]Donate to TherapsilDonate to the podcast via PayPalHave you gained new insights and perspectives from us and our guests? Consider sending financial energy our way to help support to cost of creating this powerful content.If this episode sparked something within, please let us know and leave us a review!More Modern Psychedelics: Instagram | Facebook  | WebsiteMore Lana: Instagram | YouTubeMore Zoey:Instagram | YouTube

Join our host, Larry Zeifman and this week's guests, David Wood, PhD, Partner at BLG and Spencer Hawkswell, CEO of Therapsil - together they discuss CDSA exemptions, Therapsil's work within the psychedelics industry and the future of regulations for psychedelics as medication for mental health treatment. About Zeifmans Zeifmans is a full-service tax, accounting and consulting firm based in Toronto, Canada, ranked as one of Canada's top 20 firms by revenue. Beyond the traditional offering, our services include business advisory, valuation, corporate finance, transaction services, corporate turnaround and insolvency, and estate and succession planning, supporting our 9,000+ clients through every step of the business life cycle. For more on our services relating directly to the cannabis and psychedelics industry, visit zeifmans.ca. About Borden Ladner Gervais LLP (BLG): As the largest, truly full-service Canadian law firm, Borden Ladner Gervais LLP (BLG) delivers practical legal advice for domestic and international clients across more practices and industries than any Canadian firm. With over 725 lawyers, intellectual property agents and other professionals, BLG serves the legal needs of businesses and institutions across Canada and beyond – from M&A and capital markets, to disputes, financing, and trademark & patent registration. About TheraPsil TheraPsil is a non-profit coalition dedicated to helping Canadians in medical need access legal, psilocybin-assisted psychotherapy to treat end-of-life distress. TheraPsil was formed in 2019 and is made up of healthcare professionals, patients, community members, and advocates. To meet our team, click here. After over 100 days of advocating, TheraPsil facilitated precedent-setting and tangible progress in the fight for compassionate access to psilocybin therapy when it helped 4 Canadians suffering from end-of-life distress, due to a terminal illness, access approved 'section 56 exemptions' from the Minister of Health, on August 4th 2020. This was the first time section 56 exemptions for psilocybin had been approved for patients since psilocybin was made a controlled substance in 1974, in Canada. As of March 2021, TheraPsil has now supported 27 patients in 5 different provinces access legal, psilocybin-assisted psychotherapy.

Welcome back to season 2 of Micro-dosing with Zeifmans: short podcasts on demystifying the business of Psychedelics! Join our host Zeifmans partner, Larry Zeifman, and weekly special guests, for the next 4 weeks as we continue to explore the industry of psychedelics together. Special guests this season include: Henri Sant – Cassia from The Conscious Fund, Dr. Joseph Tucker from MagicMed Industries, Doug Drydsale from Cybin, Spencer Hawkswell from Therapsil and Kelsey Ramsden from Mindcure. About Zeifmans: Zeifmans is a full-service tax, accounting and consulting firm based in Toronto, Canada, ranked as one of Canada's top 20 firms by revenue. Beyond the traditional offering, our services include business advisory, valuation, corporate finance, transaction services, corporate turnaround and insolvency, and estate and succession planning, supporting our 9,000+ clients through every step of the business life cycle. Since 1959, Zeifmans has been developing innovative solutions driven by creative insight. Nearly 60 years later, our diverse local team has grown to over 150 team members, while our membership with Nexia International – one of the world's top ten accounting and consulting networks – provides access to a global team of 3,400+ partners spanning more than 120 countries. Over 4,000 of our clients are private companies – many having been with us for more than a generation; proof that our connection with our clients remains a trusted long-term relationship based on the common goal of business growth and success. To learn more about our services relating directly to the cannabis and psychedelics industry, visit zeifmans.ca.

In this episode, Joe interviews Nick Meyers and Tyler Chandler, the makers of the documentary that has made a lot of waves over the last year (and been praised on this podcast): "Dosed." They first visited the podcast last year, a few months after the film's release, and are back to talk about the response it's received and their progress on "Dosed 2: Psilocybin and the Art Of Living," which will follow the journey of one of the patients granted legal palliative psilocybin therapy by TheraPsil last year. And although it's not mentioned, they're actually planning a "Dosed" trilogy. They talk about their early psychedelic experiences, the accusations that some of Adrianne's scenes in the film are fake, the risk profile of iboga and how age can be a factor in its efficacy, the strength and passion of the iboga community, the complications of methadone in our opioid crisis, "The Pharmacist" docuseries, pill mills, the absurdity of the drug war, and the argument for treating someone for a year vs. a lifetime. They also talk about how many people have been inspired to change their lives after watching "Dosed." If you haven't seen it yet, "Dosed" is now available on several streaming platforms. Notable Quotes “The way we did it was, as I said earlier, maybe not exactly correct, but she still had the profoundly beneficial experience, and I think that’s because her intentions were there. She was ready to make a change in her life. And anybody that’s looking to get past depression, anxiety, and/or addiction, you need to have that shift and realize it’s time to make a change and move forward.” -Tyler  On criticisms of the film: “I find it actually a little frustrating, but I can just go back just a few years in time and if I had heard about a film like this, not knowing what I know now, I would probably be like, ‘Yeah, right. That sounds hokey or kind of like, bullshit.’” -Tyler “A better judge of what it’s doing and the impact that it’s making is not a negative comment here or there; it’s the fact that we have emails in our inbox every single day from people that are expressing to us that the film changed their lives, [and] it set them on a different path, away from their struggles and towards potential solutions. It’s a very, very good feeling to be a part of something like that.” -Nick “Mental health is a problem that is actually getting worse and worse over the last few decades even though the pharmaceutical industry is supposed to have all the answers. But ‘Why is it still getting worse and worse?’ is the question.” -Tyler Links Dosedmovie.com Their last appearance on the podcast: Tyler Chandler, Nick Meyers and Adrianne – Dosed Movie: Psychedelics and Mental Health Contribute/donate to Dosed 2 Doubleblindmag.com: Vancouver Becomes First City in Canada to Decriminalize All Drugs Therapsil.ca: 4 Palliative Canadians approved for end of life psilocybin therapy through section 56(1); First legal medical exemptions for psilocybin in Canada since 1970s “The Pharmacist” docuseries on Netflix Apnews.com: Florida ‘pill mills’ were ‘gas on the fire’ of opioid crisis Vetsolutions.org About Nick Meyers and Tyler Chandler Nicholas Meyers is a Canadian producer, writer and cinematographer, known for the multi-award winning feature documentary, DOSED. He's currently in production on DOSED 2. Tyler Chandler is a Canadian documentary director, writer, and producer. His directorial debut is the award winning feature documentary, DOSED, about the therapeutic use of psychedelics like magic mushrooms and iboga to help people overcome mental health issues including depression, anxiety, and opioid addiction. Prior to DOSED Tyler produced two other features, winning three awards, and he's currently in production on DOSED 2. Support the show Patreon Leave us a review on Facebook or iTunes Share us with your friends Join our Facebook group - Psychedelics Today group – Find the others and create community. Navigating Psychedelics  

TheraPsil is a non-profit coalition of health-care professionals, patients, and advocates who are working to gain legal access to psilocybin on compassionate grounds as well as provide public education, training for health professionals, and expanding research.

Today we meet with Thomas Hartle, who was granted a federal exemption to use psilocybin mushrooms as a therapy for anxiety surrounding his Stage 4 colon cancer. Thomas has exhibited profound benefit from a session with psilocybin, which was legally facilitated by a company called TheraPsil. We have the honor to sit down with him to hear about his journey before, during and after the therapy. .Thomas Hartle is a 52-year-old father of two based in Saskatoon. He was diagnosed in 2016 and has had numerous rounds of  chemotherapy. Thomas is a welcoming, optimistic person and has invited folks in a similar position to connect with him. Topics Covered:Legislation of psilocybin assisted therapy in CanadaPsychotherapy and the unpredictable nuances in a given patientPsilocybin's influence on daily life beyond anxietyTips for how to get the most from a session with psilocybinNavigating family dynamics as a cancer patient and as recipient of psychotherapyTheraPsil, a patient advocacy group offering psilocybin to eligible patients in CanadaExistence after deathShow notes:https://therapsil.ca/https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5367557https://www.facebook.com/thomas.hartle

The CEO of TheraPsil discusses the company's journey to provide psilocybin as an option to patients who have received an end of life diagnosis.

TheraPsil is a non-profit coalition of healthcare professionals, patients, and advocates dedicated to obtaining legal access to psilocybin-assisted psychotherapy for Canadians. On August 4th, 2020, four individuals grappling with end-of-life distress who were supported by TheraPsil in their application for a Section 56 exemption to the Canadian Drugs and Substances Act were approved! This was the first time that a personal application for psilocybin therapy was approved in Canada since it was made illegal in 1974. In today's episode, we interview Spencer Hawkswell, TheraPsil's Chief Executive Officer, and discuss everything from the organization's inception through to the scientific, moral, and legal arguments in favor of expanding access to psilocybin in Canada. Our conversation includes tactical tips for grassroots activists, discussions of what's on the horizon for their organization, as well as calls-to-action and information for advocates and patients in palliative care. Links to additional topics we discussed: Find out if you qualify for TheraPsil's support: https://therapsil.ca/patients/ Read more about the scientific, moral, and legal arguments in favour of access: https://therapsil.ca/reasoning/ Dig into the academic research TheraPsil has compiled informing their reasoning: https://therapsil.ca/bibliography/ Learn more about Section 56 exemptions: https://www.canada.ca/en/health-canada/services/health-concerns/controlled-substances-precursor-chemicals/exemptions.html Read a Canadian Member of Parliament's letter addressed to the Minister of Health on this topic: https://therapsil.ca/letter-from-marcus-powlowski-to-minister-patty-hajdu/#more-999 Watch the full video testimonials from patients like Thomas and Laurie on their YouTube channel: https://www.youtube.com/channel/UCG7KAXDjoNH2i05KGW3vmsw Follow us on Twitter @Arminkhaya and @Colinrball and DM us your thoughts, questions, and feedback :)